Accueil   Diary - News   All news ImmunID to Present at Cavendish Global Health Impact Forum

ImmunID to Present at Cavendish Global Health Impact Forum

ImmunID, an immune molecular diagnostics company, announced today it will be presenting at the Cavendish Global Health Impact Forum taking place November 10-13th at Oxford University in the United Kingdom. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. ImmunID presented last May at the previous Global Health Impact Forum which was held at the United Nations Headquarters and The Rockefeller University in New York. Michael Moffat, Cavendish co-founder and President said, “ImmunID’s presentation in May at the New York forum provided a major contribution to the Cavendish community. We are glad they will once again be sharing their important story this November at Oxford. The quality and originality of ImmunID’s research and scientific insights in cancer immune diagnostics positions them to make a major contribution to cancer immunotherapy by the identification of immune competent patients likely to respond to treatment.”

 

Read the press release

 ImmunID : diagnostic moléculaire immunitaire